Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration

Details for Australian Patent Application No. 2005216707 (hide)

Owner Pfizer Products Inc.

Inventors Boettner, Wayne Alan; Miskell, Christine Edna

Agent Allens Arthur Robinson

Pub. Number AU-A-2005216707

PCT Pub. Number WO2005/082419

Priority 60/540,644 30.01.04 US

Filing date 6 January 2005

Wipo publication date 9 September 2005

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/082419 Priority application(s): WO2005/082419

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216709-Antimicrobial preservatives to achieve multi-dose formulation using betacyclodextrins for liquid dosage forms

2005216706-NK-1 receptor antagonists anesthesia recovery